DHEA – Dehydroepiandrosterone


  1. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement productsJAMA. (1998)
  2. Omura Y. Beneficial effects and side effects of DHEA: true anti-aging and age-promoting effects, as well as anti-cancer and cancer-promoting effects of DHEA evaluated from the effects on the normal and cancer cell telomeres and other parametersAcupunct Electrother Res. (2005)
  3. Orentreich N, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthoodJ Clin Endocrinol Metab. (1984)
  4. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersEndocr Rev. (2011)
  5. Traish AM, et al. Dehydroepiandrosterone (DHEA)–a precursor steroid or an active hormone in human physiologyJ Sex Med. (2011)
  6. Chung BC, et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissuesProc Natl Acad Sci U S A. (1987)
  7. Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatmentCurr Opin Endocrinol Diabetes Obes. (2010)
  8. Patel SS, et al. 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovaryReprod Sci. (2010)
  9. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids.
  10. Fitzpatrick JL, et al. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractionsArch Biochem Biophys. (2001)
  11. Le Mée S, et al. 7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytesSteroids. (2008)
  12. Morfin R, Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in miceJ Steroid Biochem Mol Biol. (1994)
  13. El Kihel L. Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)–recent reportsSteroids. (2012)
  14. Robinzon B, Prough RA. Interactions between dehydroepiandrosterone and glucocorticoid metabolism in pig kidney: nuclear and microsomal 11beta-hydroxysteroid dehydrogenasesArch Biochem Biophys. (2005)
  15. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11β-hydroxysteroid dehydrogenases?.
  16. Labrie F, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in womenJ Steroid Biochem Mol Biol. (2006)
  17. Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3)J Biol Chem. (2002)
  18. Liu D, et al. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expressionEndocrinology. (2007)
  19. Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptorSteroids. (2004)
  20. Martina V, et al. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjectsClin Endocrinol (Oxf). (2006)
  21. Liu D, et al. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanismsEndocrinology. (2008)
  22. Radford DJ, et al. Dehdyroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generationMol Endocrinol. (2010)
  23. Hennebert O, et al. Anti-inflammatory effects and changes in prostaglandin patterns induced by 7beta-hydroxy-epiandrosterone in rats with colitisJ Steroid Biochem Mol Biol. (2008)
  24. Chen F, et al. Direct agonist/antagonist functions of dehydroepiandrosteroneEndocrinology. (2005)
  25. Sandra N, et al. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell linesSteroids. (2012)
  26. Orentreich N, et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal menJ Clin Endocrinol Metab. (1992)
  27. Bélanger A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old menJ Clin Endocrinol Metab. (1994)
  28. Ponholzer A, et al. Association of DHEA-S and estradiol serum levels to symptoms of aging menAging Male. (2002)
  29. Arlt W, et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretionJ Clin Endocrinol Metab. (2001)
  30. Labrie F, et al. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal womenJ Steroid Biochem Mol Biol. (2007)
  31. Labrie F, et al. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEAJ Steroid Biochem Mol Biol. (2008)
  32. Bélanger A, et al. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humansTrends Endocrinol Metab. (2003)
  33. Hum DW, et al. Characterization of UDP-glucuronosyltransferases active on steroid hormonesJ Steroid Biochem Mol Biol. (1999)
  34. Turgeon D, et al. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily membersEndocrinology. (2001)
  35. Labrie F, et al. Metabolism of DHEA in postmenopausal women following percutaneous administrationJ Steroid Biochem Mol Biol. (2007)
  36. Acacio BD, et al. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young menFertil Steril. (2004)
  37. Auci DL, et al. A potential role for 5-androstene-3β,7β,17β-triol in obesity and metabolic syndromeObesity (Silver Spring). (2011)
  38. Thaler LM, Blevins LS Jr. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiencyJ Clin Endocrinol Metab. (1998)
  39. Hucklebridge F, et al. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakeningPsychoneuroendocrinology. (2005)
  40. Granger DA, et al. Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adultsPsychoneuroendocrinology. (1999)
  41. Oskis A, et al. Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescentsStress. (2012)
  42. Ahn RS, et al. Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levelsYonsei Med J. (2007)
  43. Matchock RL, Dorn LD, Susman EJ. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls during pubertyChronobiol Int. (2007)
  44. Markopoulou K, et al. The ratio of cortisol/DHEA in treatment resistant depressionPsychoneuroendocrinology. (2009)
  45. Young AH, Gallagher P, Porter RJ. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patientsAm J Psychiatry. (2002)
  46. Michael A, et al. Altered salivary dehydroepiandrosterone levels in major depression in adultsBiol Psychiatry. (2000)
  47. Lawson EA, et al. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosaJ Clin Endocrinol Metab. (2009)
  48. Gallagher P, et al. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorderSchizophr Res. (2007)
  49. Ritsner M, et al. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patientsEur Neuropsychopharmacol. (2004)
  50. Strous RD, et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophreniaArch Gen Psychiatry. (2003)
  51. Nachshoni T, et al. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trialSchizophr Res. (2005)
  52. Ritsner MS, et al. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trialJ Clin Psychopharmacol. (2006)
  53. Cleare AJ, O’Keane V, Miell JP. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndromePsychoneuroendocrinology. (2004)
  54. Ritsner M, et al. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophreniaNeuropsychopharmacology. (2005)
  55. Pawlikowski M, et al. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly womenNeuro Endocrinol Lett. (2002)
  56. Miodownik C, et al. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patientsClin Neuropharmacol. (2011)
  57. Liu TC, et al. Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval trainingEur J Appl Physiol. (2013)
  58. Komesaroff PA. Unravelling the enigma of dehydroepiandrosterone: moving forward step by stepEndocrinology. (2008)
  59. Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen.
  60. Kurzman ID, et al. The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: a clinical trialObes Res. (1998)
  61. Marder W, et al. Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot studyLupus. (2010)
  62. Jankowski CM, et al. Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipidsClin Endocrinol (Oxf). (2011)
  63. Barnhart KT, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of lifeJ Clin Endocrinol Metab. (1999)
  64. Jedrzejuk D, et al. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolismAging Male. (2003)
  65. Srinivasan M, et al. Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly menJ Clin Endocrinol Metab. (2010)
  66. Boxer RS, et al. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristicsAge Ageing. (2010)
  67. Kiechl S, et al. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study)Arterioscler Thromb Vasc Biol. (2000)
  68. Omura Y, et al. Bi-directional transmission of molecular information by photon or electron beams passing in the close vicinity of specific molecules, and its clinical and basic research applications: 1) Diagnosis of humans or animal patients without any direct contact; 2) Light microscopic and electron microscopic localization of neuro-transmitters, heavy metals, Oncogen C-fos (AB2), etc. of intracellular fine structures of normal and abnormal single cells using light or electro-microscopic indirect Bi-Digital O-Ring TestAcupunct Electrother Res. (1992)
  69. Omura Y. Electro-magnetic resonance phenomenon as a possible mechanism related to the „bi-digital o-ring test molecular identification and localization method“Acupunct Electrother Res. (1986)
  70. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trialJAMA. (2004)
  71. Genazzani AD, et al. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroidsFertil Steril. (2003)
  72. Talaei A, et al. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose toleranceHormones (Athens). (2010)
  73. Lasco A, et al. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal womenEur J Endocrinol. (2001)
  74. Casson PR, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal womenFertil Steril. (1995)
  75. Diamond P, et al. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal womenJ Endocrinol. (1996)
  76. Kawano H, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in menJ Clin Endocrinol Metab. (2003)
  77. Nestler JE, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal menJ Clin Endocrinol Metab. (1988)
  78. Panjari M, et al. The safety of 52 weeks of oral DHEA therapy for postmenopausal womenMaturitas. (2009)
  79. Morales AJ, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing ageJ Clin Endocrinol Metab. (1994)
  80. Igwebuike A, et al. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal womenJ Clin Endocrinol Metab. (2008)
  81. Basu R, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or womenDiabetes. (2007)
  82. Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal womenJ Clin Endocrinol Metab. (1990)
  83. Brown GA, et al. Effect of oral DHEA on serum testosterone and adaptations to resistance training in young menJ Appl Physiol. (1999)
  84. Liao YH, et al. Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damageEur J Appl Physiol. (2012)
  85. Ostojic SM, Calleja J, Jourkesh M. Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletesChin J Physiol. (2010)
  86. Vogiatzi MG, et al. Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistanceMetabolism. (1996)
  87. Yamada Y, et al. Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly personsEndocr J. (2007)
  88. Taniguchi S, et al. The antiobesity effect of dehydroepiandrosterone in castrated or noncastrated obese Zucker male ratsObes Res. (1995)
  89. Kajita K, et al. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytesEndocrinology. (2003)
  90. Richards RJ, Porter JR, Svec F. Long-term oral administration of dehydroepiandrosterone has different effects on energy intake of young lean and obese male Zucker rats when compared to controls of similar metabolic body sizeDiabetes Obes Metab. (1999)
  91. Abadie JM, et al. Dehydroepiandrosterone alters Zucker rat soleus and cardiac muscle lipid profilesExp Biol Med (Maywood). (2001)
  92. Pham J, et al. The effect of dehydroepiandrosterone on Zucker rats selected for fat food preferencePhysiol Behav. (2000)
  93. Pasiakos SM, et al. Appetite and endocrine regulators of energy balance after 2 days of energy restriction: insulin, leptin, ghrelin, and DHEA-SObesity (Silver Spring). (2011)
  94. Ryu JW, et al. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF ratsBiochem Biophys Res Commun. (2003)
  95. de Heredia FP, et al. Effect of dehydroepiandrosterone on protein and fat digestibility, body protein and muscular composition in high-fat-diet-fed old ratsBr J Nutr. (2007)
  96. Alberg AJ, et al. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancerCancer Epidemiol Biomarkers Prev. (2000)
  97. Yoshida S, et al. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell linesSteroids. (2003)
  98. Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women.
  99. Morales AJ, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and womenClin Endocrinol (Oxf). (1998)
  100. Libè R, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalismJ Endocrinol Invest. (2004)
  101. Kritz-Silverstein D, et al. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) TrialJ Am Geriatr Soc. (2008)
  102. Dayal M, et al. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipidsJ Womens Health (Larchmt). (2005)
  103. Genazzani AR, et al. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiencyAging Male. (2004)
  104. Bernardi F, et al. Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphinFertil Steril. (2005)
  105. Hunt PJ, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trialJ Clin Endocrinol Metab. (2000)
  106. Arlt W, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiencyN Engl J Med. (1999)
  107. Abrams DI, et al. Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled studyAIDS Res Hum Retroviruses. (2007)
  108. Eylert MF, Persad R. Management of prostate cancerBr J Hosp Med (Lond). (2012)
  109. Weiss EP, et al. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humansAging (Albany NY). (2011)
  110. Sun Y, et al. Treatment of osteoporosis in men using dehydroepiandrosterone sulfateChin Med J (Engl). (2002)
  111. Morales A, et al. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiencyAging Male. (2009)
  112. Reiter WJ, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled studyUrology. (1999)
  113. Arnold JT, et al. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cellsAm J Physiol Endocrinol Metab. (2005)
  114. Rhoden EL, et al. Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in ratsJ Urol. (2003)
  115. Brooke AM, et al. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacementClin Endocrinol (Oxf). (2006)
  116. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults.
  117. Percheron G, et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trialArch Intern Med. (2003)
  118. Welle S, Jozefowicz R, Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humansJ Clin Endocrinol Metab. (1990)
  119. Wolf OT, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and menJ Clin Endocrinol Metab. (1997)
  120. Nair KS, et al. DHEA in elderly women and DHEA or testosterone in elderly menN Engl J Med. (2006)
  121. Baulieu EE, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issueProc Natl Acad Sci U S A. (2000)
  122. Felt V, Stárka L. Metabolic effects of dehydroepiandrosterone and Atromid in patients with hyperlipaemiaCor Vasa. (1966)
  123. Flynn MA, et al. Dehydroepiandrosterone replacement in aging humansJ Clin Endocrinol Metab. (1999)
  124. Wolkowitz OM, et al. Dehydroepiandrosterone (DHEA) treatment of depressionBiol Psychiatry. (1997)
  125. Jankowski CM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trialJ Clin Endocrinol Metab. (2006)
  126. Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced menJ Gerontol A Biol Sci Med Sci. (1997)
  127. Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effectsAnn N Y Acad Sci. (1995)
  128. Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial.
  129. van Thiel SW, et al. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trialJ Clin Endocrinol Metab. (2005)
  130. Koó E, et al. Effect of dehydroepiandrosterone on hereditary angioedemaKlin Wochenschr. (1983)
  131. Callies F, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacityJ Clin Endocrinol Metab. (2001)
  132. Abrahamsson L, Hackl H. Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot or dehydroepiandrosterone (DHEA) oenanthateMaturitas. (1981)
  133. Genazzani AD, et al. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal womenFertil Steril. (2001)
  134. Casson PR, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trialFertil Steril. (1998)
  135. Løvås K, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trialJ Clin Endocrinol Metab. (2003)
  136. Calvo E, et al. Pangenomic changes induced by DHEA in the skin of postmenopausal womenJ Steroid Biochem Mol Biol. (2008)
  137. Williams MR, et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptorsJ Clin Endocrinol Metab. (2004)
  138. Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and menClin Endocrinol (Oxf). (2000)
  139. Hackbert L, Heiman JR. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal womenJ Womens Health Gend Based Med. (2002)
  140. Stomati M, et al. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopauseGynecol Endocrinol. (2000)
  141. Barton DL, et al. Dehydroepiandrosterone for the treatment of hot flashes: a pilot studySupport Cancer Ther. (2006)
  142. Johannsson G, et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trialJ Clin Endocrinol Metab. (2002)
  143. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison’s disease.
  144. Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal womenDiabetes. (2005)
  145. Gordon CM, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trialJ Clin Endocrinol Metab. (2002)
  146. Brooke AM, et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacementJ Clin Endocrinol Metab. (2006)
  147. Bilger M, et al. Androgen replacement in adolescents and young women with hypopituitarismJ Pediatr Endocrinol Metab. (2005)
  148. van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosusArthritis Rheum. (1994)
  149. Petri MA, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosusArthritis Rheum. (2004)
  150. Chang DM, et al. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trialArthritis Rheum. (2002)
  151. Barry NN, McGuire JL, van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical responseJ Rheumatol. (1998)
  152. Nordmark G, et al. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosusAutoimmunity. (2005)
  153. Petri MA, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trialArthritis Rheum. (2002)
  154. van Vollenhoven RF, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosusLupus. (1999)
  155. Schubert K, Wehrberger K, Hobe G. Androsta-3,5-diene-7,17-dione: isolation from urine and formation from 7-keto-dehydro-epiandrosterone sulphate under various conditions of hydrolysisEndocrinol Exp. (1971)
  156. Marwah A, Marwah P, Lardy H. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric studyJ Chromatogr B Analyt Technol Biomed Life Sci. (2002)
  157. Numazawa M, et al. Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromataseJ Med Chem. (1994)
  158. Muller M, et al. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly menJ Clin Endocrinol Metab. (2006)
  159. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue.
  160. Yamada S, et al. Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairmentGeriatr Gerontol Int. (2010)
  161. von Mühlen D, et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trialOsteoporos Int. (2008)
  162. Ma H, et al. Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study reportBMC Complement Altern Med. (2011)
  163. Parsons TD, et al. Dhea supplementation and cognition in postmenopausal womenInt J Neurosci. (2006)
  164. Wallace MB, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in menMed Sci Sports Exerc. (1999)
  165. Kenny AM, et al. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older womenJ Am Geriatr Soc. (2010)
  166. Genazzani AR, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal womenGynecol Endocrinol. (2006)
  167. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVFHum Reprod. (2006)
  168. Taylor MK, et al. Effects of dehydroepiandrosterone supplementation during stressful military training: a randomized, controlled, double-blind field studyStress. (2012)
  169. Wiser A, et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective studyHum Reprod. (2010)
  170. Kahn AJ, et al. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly menJ Clin Endocrinol Metab. (2002)
  171. Weiss EP, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on boneAm J Clin Nutr. (2009)